Department of Oral pathology and Microbiology, Centre for dental education and research, All India Institute of Medical Sciences, New Delhi, India.
CSIR, Institute of Genomics and Integrative Biology, North campus, Delhi 110007, India.
Pathol Res Pract. 2024 Nov;263:155624. doi: 10.1016/j.prp.2024.155624. Epub 2024 Sep 26.
Benign fibro-osseous lesions have long been an area of diagnostic difficulty due to overlapping of histological and radiological features. Differentiating between these lesions is crucial because of their unique pathogenesis and biological behavior. Ossifying fibroma (OF) and fibrous dysplasia (FD) are the most prevalent lesions. However, not all FD or OF exhibit the typical radiological and histopathological features. In such situations, molecular-level investigations could be essential for precise identification and differentiation.
To evaluate the screening of GNAS and CDC73 mutations in blood and formalin fixed tumor tissues (FFTT) of FD and OF cases.
Six blood samples (three cases of FD and JOF each) and thirteen FFTT (six cases of FD and seven cases of JOF) were included in the study. DNA was extracted from peripheral blood samples using salting out method followed by whole exome sequencing. Multiple efforts were made to extract DNA from tumor tissues using various protocols, but no measurable yield was obtained.
DNA derived from blood samples gave successful DNA library preparation and subsequent exome sequencing data generation. We report a pathogenic GNAS mutation (exon8:c.G602A:p.R201H) associated with McCune-Albright syndrome and a novel benign mutation identified in a case of FD (GNAS(NM_000516.7):c.257+687_257+688del) whereas none of the subjects of JOF displayed GNAS and/or CDC73 mutation.
Study observed mutations in GNAS gene in blood samples from FD cases. However, a limitation is that only DNA extracted from blood underwent successful exome sequencing. Potential reason for low-quality DNA extraction from tissue may be attributed to prior fixation procedures conducted on bone specimens.
由于组织学和影像学特征的重叠,良性纤维骨性病变一直是诊断的难点领域。区分这些病变至关重要,因为它们具有独特的发病机制和生物学行为。骨化性纤维瘤(OF)和纤维结构不良(FD)是最常见的病变。然而,并非所有 FD 或 OF 都表现出典型的放射学和组织病理学特征。在这种情况下,分子水平的研究对于准确识别和区分可能至关重要。
评估 GNAS 和 CDC73 基因突变在 FD 和 OF 病例的血液和福尔马林固定肿瘤组织(FFTT)中的筛选。
本研究纳入了 6 份血液样本(3 例 FD 和 1 例 JOF)和 13 份 FFTT(6 例 FD 和 7 例 JOF)。使用盐析法从外周血样本中提取 DNA,然后进行全外显子组测序。我们尝试了多种方法从肿瘤组织中提取 DNA,但均未获得可测量的产量。
血液样本的 DNA 成功制备了 DNA 文库,并随后生成了外显子组测序数据。我们报告了一个与 McCune-Albright 综合征相关的致病性 GNAS 突变(exon8:c.G602A:p.R201H)和一个在 FD 病例中发现的新的良性突变(GNAS(NM_000516.7):c.257+687_257+688del),而 JOF 病例的受试者均未显示 GNAS 和/或 CDC73 突变。
本研究观察到 FD 病例血液样本中 GNAS 基因的突变。然而,一个限制是只有从血液中提取的 DNA 进行了成功的外显子组测序。从组织中提取低质量 DNA 的潜在原因可能归因于对骨标本进行的先前固定程序。